News

Medscape2d
Continuous Glucose Monitoring Devices May Lead to False Dietary Changes, Study Finds
Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...
CNET on MSN6d
The FDA Just Cleared the Dexcom G7 15-Day, the Longest-Lasting CGM Wearable
The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.
The Cardiology Advisor1d
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.
clinicaladvisor.com3d
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
has cleared the Dexcom G7 15 Day continuous glucose monitoring (CGM) system for individuals 18 years and older with diabetes. The Dexcom G7 15 Day CGM system is a wearable sensor that continuously ...
Remote Patient Monitoring (RPM) Market Research by Offering, Device, Function, Application, End User, & Region - Global Forecast to 2030
The global remote patient monitoring market is forecasted to surge from USD 27.72 billion in 2024 to USD 56.94 billion by ...
This Smartwatch Monitors Blood Pressure By Tapping the Watch Face
The Asus VivoWatch 6 Aero should let you stick your finger on the watch face to get a blood oxygen and blood pressure reading ...
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring ...
Asian News International on MSN9d
Ambrosia Launches India's First 24x7 Real-Time Glucose (A-CGM) & Stress Monitoring Service - A Game-Changer in Health Tech
Ambrosia, a global leader in real-time health monitoring, has launched India's first 24x7 real-time glucose and stress ...